Maiden Pharma under scrutiny after 66 children died consuming cough syrup in Gambia
Sunday, 9 October 2022 The drug regulators have obtained samples of cold and cough medicine from Maiden Pharmaceuticals in response to a WHO medical alert.
The World Health Organisation on Wednesday warned that four "contaminated" and "substandard" cough syrups, allegedly produced by Maiden Pharmaceuticals Limited based in Haryana's Sonipat could be the reason for the deaths of at least 66 children in The Gambia. This has brought at least 4 cough syrups...
In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..
In the Gambia, parents react to the recent measures taken by the authorities to stop the import of cough syrups that have been linked to the deaths of 69 children in the country. "If it is due..
Earlier on Monday, the Indian Pharma company had released a statement over the reports linking its cough syrups to the deaths of 66 children in Gambia. Zee News
The WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia. DNA Also reported by •newKerala.com
Sunday, 9 October 2022
![Cough Syrup [Video]](https://video.newsserve.net/300/v/20221013/1665650607-Cough-Syrup.jpg)
![Cough Syrup in Gambia [Video]](https://video.newsserve.net/300/v/20221013/1665649994-Cough-Syrup-in-Gambia.jpg)
